# Tevogen Inc.: Form 8-K, filed Aug 26, 2026

- Company: [Tevogen Inc.](/companies/tvgn.md) (CIK 1860871)
- Form: 8-K
- Filed: 2026-08-26
- Accepted by EDGAR: Aug 26, 2026, 15:10 ET
- Period: 2026-08-24
- Accession: 0001493152-26-040216
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1860871/000149315226040216/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1860871/000149315226040216/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1860871/000149315226040216/form8-k.htm

Filed Aug 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-040216. Last ingested by Listed: Nov 4, 2026, 18:10 ET. No prices; not investment advice.